Titled the 'Effectiveness of germicidal ultraviolet Light in an Upper room Configuration In Decreasing COVID-19 in Aged-care Residential facilities (ELUCIDAR)', this scientific trial will see if germicidal ultraviolet light can reduce the level of COVID-19 in an aged care setting.
Timeline
The ELUCIDAR study initially ran for 12-months from 15 November 2024 to 14 November 2025.
The trial has now been extended for an additional 12 months.
From 1 July 2026, the Burnet Institute will be leading the ELUCIDAR study.
For more information, see Using ultraviolet light to reduce COVID‐19 in aged care homes (ELUCIDAR study) on the Burnett website.
Updated